Category Archives: Uncategorized

Jason Hope’s Philanthropic activities and his Opinions on the Future of the Internet of Things

Jason Hope is a leading serial entrepreneur who has a special interest in technology. The businessman is also an active philanthropist and technology specialist who is taking the competitive market by a storm. At the moment, Jason Hope is based in Scottsdale, Arizona, and his business ventures are found in many parts of the country. Jason Hope has a great passion for his work, especially when it comes to technology, and he is doing his best so that he can change the modern society using technology.

Jason Hope has accomplished a lot in the academic field. According to his portfolio, Hope is one of the alumni of the prestigious Arizona State University. The businessman also attended an institution known as ASU Carey School of Business where he sharpened his skills in business. His MBA in finance has played a primary role in his successful career life. Although he has several ventures in the world, the successful entrepreneur has several charity initiatives that have been started to change the lives of the communities close to him. In the recent time, the businessman has shown a special interest in politics, and he is making a huge impact in the history of the United States.

Jason Hope has been quoted several times concerning the internet of things. According to him, this kind of technology will take the world to a better level in the recent future. Most of the analysts in the world agree with these sentiments, and they say that this technology will reshape the ways of mankind. The businessman says that this technology is unique and very complicated, and it will launch several activities that will make the lives of people easier. Jason Hope says that the technology has already been impressed by some of the large corporations in the world. In the future, other institutions will be forced to use so that they can cope with the high competition.

According to Jason Hope, businesses will have no choice but embrace the Internet of Things in their businesses. The market has changed in the recent times, and individuals who have refused to invest in the new technologies will have a hard time trying to cope with the changes. Hope, however, says that the new changes will not have a negative impact on the lives of the investors or their customers in the future. Things will be done easier with this technology if more people accept and learn about it.

 

Amicus Therapeutics: Dedication to Healing Beyond Atypical Diseases

Based in Cranbury, New Jersey, Amicus Therapeutics is a global biopharmaceutical corporation founded in February of 2002. By 2008 had gone public and had also expanded from their initial New Jersey site to a new facility in San Diego, California. In 2010, the organization received two substantial grants from the Michael J. Fox Foundation and the Alzheimer’s Drug Discovery Foundation for collaborative studies and pre-clinical work with UCLA’s David Geffen School of Medicine and the Icahn School of Medicine at Mount Sinai, respectively. Amicus Therapeutics prides itself on being the spearhead of advanced therapeutic treatments for a wide variety of devastating uncommon diseases, specifically related to irregularities that are commonly known as Lysosomal Storage Disorders, and boast having a resilient developmental conduit of treatments for an assortment of human genetic diseases. In the year 2014, Amicus Therapeutics was renowned for conceivably possessing “the broadest portfolio of small molecule pharmacological chaperones” in the pharmaceutical industry (Crunchbase).

The patients matter, and it shows through their dedication to developing more up-to-date, superior therapy options to chose from in battling each of these disorders. Amicus Therapeutics is constantly striving to expound upon their list of treatments in hopes of assisting a wider scope of these diseases, and supporting those who suffer through them. The organization is passionate about providing aid and assistance with helpful, real-life implementations to help those who suffer from these disorders and cope with the daily struggles that they bring. The corporation uses their experiences and interactions with their patients and those affected by their illnesses to constantly improve and find new and better options for their clinical trials (http://www.marketwatch.com/investing/stock/fold). Amicus Therapeutics’ mission statement, in a paraphrased summary, states that they strive to remain a leader in therapeutic treatment of infrequent and orphan diseases, to build long-term value for their shareholders, and always encourage a united work-front and respect for each team member and what they bring to the company. Their dedication to each and every patient, those patient’s families, and their own team members is what leads their ability to provide healing beyond the disease.

Salvi Rafael Folch Viadero’s All-Important Role at Grupo Televisa

     Many media companies around the world are going digital. And over the last few years, Mexico has emerged as the most successful country in digital journalism in Latin America. Many of the old media houses are embracing the power of the internet and taking advantage of social media and other digital platforms to improve their readership and engagement levels. Grupo Televisa, S.A., was among the first media companies in Mexico to go digital. Under the leadership of Salvi Rafael Folch Viadero and other executives at the company, Grupo Televisa has managed to reach even more people in Mexico and other Latin America countries as well.

Other top players in the media industry in Mexico that have gone digital include Evoga Entertainment, MVS Communicaciones, Grupo CIE, and Grupo Reforma among others. The competition in the media industry is fierce and any company cannot keep up with the demands of the industry risks sinking into oblivion.This has greatly improved the quality of information and entertainment provided to the masses and helped the industry to grow.

About Salvi Rafael Folch Viadero

Salvi Rafael Folch Viadero is the Chief Financial Officer of Grupo Televisa. He also serves on the board of directors of the company. Salvi Rafael has worked with Grupo Televisa for a while now and has held several other leadership positions at the company. His extensive experience in the media industry in Latin America makes him a great asset to Grupo Televisa.

Salvi Rafael Folch Viadero’s role as CFO of Grupo Televisa cannot be taken lightly. He is the man in charge of making all the important financial decisions that could either make or break company. He has also been very instrumental in the company’s move to digital journalism. In 2014, he was recognized as one of the 25 top CFOs in Mexico.

Conclusion

The advance of the internet age has brought about many changes to the media industry in Mexico. The people of Mexico and the whole of Latin America have benefited greatly from this. With people like Salvi Rafael Folch Viadero at the helm of the most influential media company in Latin America, this trend is expected to continue and even more developments are bound to be experienced in the industry.

What A Publicist

     Publicist Alexandre Gama does not waste any time beating around the bushes, nor does he procrastinate, particularly when it comes to his life’s best work – writing copy and writing it well. He would attest, and Wikipedia would likewise not disagree, that he has written well over 777,000 printed articles and news pieces altogether and that such a number is minimal when compared to what he has yet to write. His goals and passionate pursuits for excellence are perhaps what have pushed him into writing in the first place, which he has done more than well for nearly 13 different agencies.

In fact, when you count the number of articles and other relevant pieces published for other agencies, but written by him, that number only grows. He attests that it’s impossible to count his past works. He has had much continued success in the fields of copywriting and web design.

Cancer Treatment Centers of America Partners Up for Technology

The for-profit group known as the Cancer Treatment Centers of America has recently partnered up with NantHealth and Allscripts to help with a solution in the workplace of healthcare.

Cancer Treatment Centers of America, or CTCA, has been collaborating with both groups because they have come up with a technical solution for the clinical systems. The solution can enable a program called “eviti,” which is a NantHealth clinical support solution, to have access to clinical workflows that operate with the electronic health records (EHR) provided by Allscripts.

The Clinical Pathways Program, as it is called, allows for patients to be fully informed about the cancer treatment process while the physician can focus on their work at the same time. The interface of the operating system itself was put together with the help and expert opinions of oncologists all over the states and also acts an archive for data regarding the evolution of cancer. The treatment platform program provides useful aides such as a comparison for all treatment options, including the costs, treatment programs specific to the patient and their health and even real time functionality.

Cancer Treatment Centers of America is a national group that is for-profit that was founded in 1988 and serves as a network for five specific hospitals that serve cancer patients all over the United States. The CTCA is headquartered in Boca Raton, Florida and is a private health system.

The CTCA takes part in different approaches when it comes to treating a patient’s cancer, ranging from surgery to different radiation treatments to immunotherapy to chemotherapy. The group is constantly rated as one of the top hospitals in the country when it comes to quality and care of patients during treatment. CTCA provides thorough explanations regarding the treatment options and encourages participation in family decisions.

Follow CTCA on Twitter @CancerCenters

http://www.prnewswire.com/news-releases/cancer-treatment-centers-of-america-partners-with-allscripts-and-nanthealth-to-launch-clinical-pathways-a-comprehensive-and-custom-oncology-treatment-platform-300414105.html

 

Cancer Treatment Centers of America Helps to Launch New Platform that will Help the World of Oncology Be More Effective

The world of oncology is dedicated to the study, research, and treatment of cancer. Cancer is a devastating disease that has affected the lives of millions of people and their families who must fight it every day. The fight to overcome cancer can feel like an uphill battle and many people feel like their treatment options are limited. Thanks to Cancer Treatment Centers of America partnering up with NantHealth and Allscripts, together they have been able to launch a new platform called Clinical Pathways.

Clinical Pathways will help to change the standard of care patients can expect when they seek out treatment. The idea behind the newly launched platform is to provide appropriate treatment options to patients to help eliminate the potential guesswork that is often done by clinicians. The new data and research that goes on in oncology will become more widely available and easy to access, allowing oncologists to specialize the treatment options for their patients.
Cancer Treatment Centers of America takes a similar approach with their patients, believing in personalized care to ensure they have the best treatment options available to them. The heart of CTCA stems from how it was founded originally in 1988 by Richard J. Stephenson. His mother passed away from cancer, but during her time with the disease, he wasn’t satisfied with the treatment options available to her. He went on to found the first CTCA at Midwestern Regional Medical Center in Zion, Illinois.
Ever since CTCA has been founded it has slowly begun to expand, with four more hospitals opening between 2005 to 2012. The organized since then has even become the first international patient concierge and information office. CTCA opened in Lomas de Chapultepec neighborhood in Mexico City on April 20, 2015. CTCA has continued to maintain an active presence in other areas of the world too like Latin America, the Middle East, and the Caribbean.

Avi Weisfogel Advances Sleep Apnea Research

Connecting The Dots

Avi Weisfogel and his research team at Dental Sleep Masters are making major breakthroughs in the research of sleep apnea. Weisfogel’s research has challenged the view that sleep apnea is nothing more than a nuisance with no connection to any serious health issues. According to the research conducted by Avi Weisfogel there is a strong connection between sleep apnea and numerous chronic illnesses. Sleep apnea patients are much more likely to suffer from diseases such as diabetes and stroke than the general population. Taking this into consideration he created Dental Sleep Masters to help dentists and physicians work together to develop new treatment options.

 

 

The Dream Team

The key to the research of Dental Sleep Masters is the combination of dentists and physicians. While Wiesfogel’s background in dentistry has helped him immensely in his treatment of sleep apnea there are aspects of sleep apnea that are beyond the scope of his practice. Working with physicians allows him to use the knowledge of experts outside of his field to build a better understanding of exactly what sleep apnea truly is. Much of Dental Sleep Master’s discoveries of the comorbidities of sleep apnea are attributed to the work of physicians.

 

 

The Man Behind It All

After starting his dental practice in 1999 Dr.Avi Weisfogel has spent the last 16 years acquiring an intimate knowledge of sleep disorders. He has devoted himself to developing better ways of treating sleep apnea patients and more recently in 2014 sought the assistance of phyisians for his current project Dental Sleep Masters. Thanks to his research he has developed more efficient and less invasive means of treating sleep apnea. Weisfogel hopes to use these new means of treating sleep apnea to improve the success dentists have when trying to help patients.